How to Add Phosphatidylserine to Supplement Formulations?

How to Add Phosphatidylserine to Supplement Formulations?

Phosphatidylserine is a naturally occurring phospholipid compound with well-defined biological roles in maintaining cell membrane function, nerve signal transduction, and supporting cognitive health. As a supplement ingredient, bulk phosphatidylserine is typically supplied as an extract from soybeans or sunflowers. For supplement manufacturers, the question is: How to Add Phosphatidylserine to Supplement Formulations?

What Is Phosphatidylserine ?

The physicochemical properties of bulk phosphatidylserine directly affect its performance in formulations. Commercially available phosphatidylserine raw materials are usually in powder or granular form, with a purity ranging from 20% to 70% (based on phosphatidylserine content). The remaining components include other phospholipids (such as phosphatidylcholine and phosphatidylethanolamine) and carriers (such as silica and maltodextrin). The soybean and sunflower phosphatidylserine sources provided by Guanjie Biotechn differ in their fatty acid composition: soybean-derived phosphatidylserine contains a higher proportion of polyunsaturated fatty acids, while sunflower-derived phosphatidylserine is primarily composed of oleic acid and linoleic acid. This difference affects the oxidative stability, flowability, and solubility of the raw material.

Supplement manufacturers should select the raw material specification based on the target product type:

• High-purity powder (≥50%):

This is suitable for capsules, tablets, and hard capsule fillings. High purity phosphatidylserine reduces excipient usage, but attention must be paid to the powder's hygroscopicity.

• Low-purity granules (20%-30%):

This is commonly used in soft capsules, liquid suspensions, or mixed powders. Low-purity products have better flowability due to the presence of a carrier, but the volume of a single capsule is larger.

Guanjie Biotechn offers customized specification services. Bulk phosphatidylserine manufacturers can negotiate with suppliers to determine the purity and particle size distribution based on the required dosage, manufacturing process, and cost control requirements.

How to Add Phosphatidylserine to Supplement Formulations?

The method of adding bulk phosphatidylserine varies depending on the dosage form. So how is phosphatidylserine supplement made? The following section analyzes common strategies for solid dosage forms (tablets and capsules), semi-solid dosage forms (soft capsules), and liquid dosage forms.

Hard Capsules

Hard capsules are one of the most commonly used dosage forms for phosphatidylserine formulation because they avoid exposing the raw material to high temperatures or high humidity during processing. The steps include:

• Premixing:

Bulk Phosphatidylserine powder is mixed with fillers (microcrystalline cellulose, lactose), disintegrants (crospovidone, sodium carboxymethyl starch), and lubricants (magnesium stearate, silica) in a specific ratio. Due to the hydrophobic and viscous nature of phosphatidylserine, a geometric dilution method or an incremental mixing method should be used, with the mixing time controlled at 10–15 minutes to prevent excessive shearing and particle adhesion.

• Improving Flowability:

If the raw material has poor flowability (angle of repose > 40°), 0.5%–1.5% colloidal silica or pregelatinized starch can be added.

• Dosage Control:

Each hard capsule typically contains 300–600 mg of pure phosphatidylserine, with a net content of 50–200 mg (based on purity). When using an automated capsule-filling machine, it is recommended to set the filling depth at a compression ratio between 1:1.2 and 1:1.5.

• Stability Considerations:

Soy-derived products require the addition of antioxidants (such as 0.1%–0.3% mixed tocopherols) to inhibit the oxidation of polyunsaturated fatty acids; for sunflower-derived products, the antioxidant dosage can be reduced to 0.05%–0.1%.

Tablets

Forming phosphatidylserine into tablets presents two major challenges: punch sticking (adhering to the tableting machine punch) and delayed disintegration. Solutions include:

• Granulation Steps:

Wet or dry granulation is recommended. For wet granulation, an aqueous solution of hydroxypropyl methylcellulose or povidone K30 is used as a binder. Phosphatidylserine is mixed with a diluent and then granulated. The drying temperature should be controlled at 40–50°C, as temperatures exceeding 60°C may cause phospholipid oxidation. Dry granulation is suitable for heat-sensitive products. The material is compressed into thin sheets using a roller press and then granulated.

• Lubricant Selection:

The amount of magnesium stearate needs to be precisely controlled between 0.5% and 1.0%. Excessive amounts may significantly delay disintegration. Glyceryl behenate (0.5%–2.0%) can be added to reduce sticking.

• Coating:

Film coating (such as Opadry) can mask the odor of phosphatidylserine and provide moisture protection. Sugar coating is not recommended due to its high moisture permeability.

• Hardness Requirements:

Tablet hardness should be controlled between 6–10 kP. Excessive hardness may inhibit disintegration and dissolution.

Soft Capsules

Soft capsules are suitable for liquid or semi-solid fillers. Phosphatidylserine can be dissolved or suspended in lipophilic carriers.

• Carrier Selection:

Suitable carriers include medium-chain triglycerides (MCTs), olive oil, or sunflower oil. The solubility of phosphatidylserine in MCTs is typically 5%–15% (w/w). For high-purity phosphatidylserine (≥50%), it is recommended to first mix it with lecithin at a 1:1 ratio to promote dispersion.

• Suspension Preparation:

Slowly add phosphatidylserine powder to the oil phase heated to 40–50°C, and disperse it using a high-shear mixer (1000–3000 rpm) for 15–30 minutes until no visible particles remain. Beeswax (1%–3%) can be added as a suspending agent to prevent sedimentation.

• Antioxidant System:

Add rosemary extract (0.05%–0.2%) or ascorbyl palmitate (0.01%–0.05%) to work synergistically with tocopherols.

• Gelatin Composition:

The ratio of gelatin, glycerin, and water needs to be adjusted carefully. A glycerin-to-gelatin ratio of 0.4:1 to 0.6:1 is recommended to match the lipophilicity of the filler and prevent leakage.

Liquid Supplements

Phosphatidylserine oil is insoluble in water and therefore requires solubilization techniques.

• Microemulsion System:

Use polysorbate 80 (Tween 80, 0.5%–2.0%) or polyoxyethylene castor oil (Cremophor EL) as a surfactant. Mix it with phosphatidylserine and MCT oil, then slowly add it to water to form a transparent or milky-white microemulsion.

• Cyclodextrin Inclusion:

Hydroxypropyl-β-cyclodextrin can form inclusion complexes with phosphatidylserine, improving water dispersibility. The molar ratio is typically 2:1 (cyclodextrin:phosphatidylserine).

• pH Adjustment:

Maintain the pH between 5.5 and 7.0. Acidic conditions (pH < 4) will accelerate phospholipid hydrolysis.

• Preservatives:

Add sodium benzoate (0.1%) or potassium sorbate (0.1%) to inhibit microbial growth. Note that high concentrations of surfactants may reduce the effectiveness of the preservatives.

Key Control Points in the Production Process

Supplement manufacturers should pay close attention to the following process parameters when scaling up phosphatidylserine from laboratory formulations to commercial production:

1. Mixing Uniformity

The content uniformity of bulk phosphatidylserine in the mixing hopper or V-type mixer (RSD ≤ 5%) requires strict control. Due to the density differences among raw materials (the true density of phosphatidylserine is approximately 1.0 g/cm³, while microcrystalline cellulose is approximately 1.5 g/cm³), over-mixing, which may lead to segregation, should be avoided. It is recommended to collect samples from different locations (at least 10 points) after mixing to test the content uniformity.

2. Direct Tableting vs. Granulation

For low-purity granules with good flowability (such as the 30% specification provided by Guanjie Biotech), direct tableting is possible. However, high-purity phosphatidylserine powders (≥ 50%) must be granulated; otherwise, excessive tablet weight variation (exceeding ±7%) and uneven content may occur.

3. Drying Temperature and Time

During the drying process after wet granulation, the inlet air temperature should not exceed 55°C, and the material temperature should be controlled below 45°C. Fluidized bed drying provides more uniform drying than oven drying, reducing the drying time to 20–40 minutes.

4. Metal Detection

Iron filings may be introduced during the grinding and mixing of bulk phosphatidylserine raw materials. Therefore, a metal detector (sensitivity: iron 0.5 mm, non-ferrous metals 1.0 mm, stainless steel 1.2 mm) should be installed before the tableting or filling process.

Regulatory Requirements and Labeling Declarations

Regulatory requirements for bulk phosphatidylserine supplements vary across different markets. Manufacturers must confirm the following in advance:

• USA: 

Pure Phosphatidylserine is recognized by the FDA as GRAS (Generally Recognized as Safe, GRN 000231) and can be used as a dietary supplement. The recommended daily dose is typically 100–300 mg. The label must state: “Phosphatidylserine (derived from soy/sunflower lecithin).” 

• EU: 

According to EU 2017/2470, natural phosphatidylserine is classified as a Novel Food, with a permitted maximum dose of 300 mg/day for adults. Product labels must include “Added Phosphatidylserine” along with the source declaration. 

• China: 

Phosphatidylserine is listed in the Health Food Raw Material Catalogue (2023 Edition) and can be used in products claiming to “improve memory.” Toxicological and functional test reports are required, and the purity level and daily intake must be clearly stated in the formulation. 

• Other Countries: 

Markets such as Japan and Australia allow it as a general food ingredient, but it must comply with local additive regulations and approved ingredient lists. 

As a professional bulk phosphatidylserine supplier, Guanjie Biotech offers phosphatidylserine products from both soybean and sunflower sources, in various purity grades. The company has its own R&D center, capable of customizing particle size, bulk density, and antioxidant premix specifications according to B2B customer needs. All products undergo HPLC testing to determine phosphatidylserine content, and peroxide value, acid value, and heavy metal residue are controlled. Supplement manufacturers requiring technical support or sample testing can contact info@gybiotech.com to obtain Technical Data Sheets (TDS) and Material Safety Data Sheets (MSDS).

Problems In phosphatidylserine Process

Problems: Possible causes: Solutions:

Capsule contents clumping Phosphopeptide is hygroscopic. Reducing ambient humidity (<40% RH); increasing silica usage to 2%

Tablet disintegration time > 30 minutes Excessive magnesium stearate or excessive compression pressure. Reducing magnesium stearate to 0.5%; reducing hardness to below 8 kP

Soft capsule leakage Insufficient surface tension of the filler. Adjusting the plasticizer ratio in gelatin; increasing filler viscosity (adding 0.5% hydrogenated vegetable oil)

Sedimentation in liquid products Phosphopeptide recrystallization. Increasing surfactant concentration; using finer particle size raw materials (D90 < 50 μm)

Oxidative odor (rancid smell) Insufficient antioxidants or oxygen leakage in the packaging. Increasing mixed tocopherols to 0.3%; switching to aluminum foil bags or blister packaging

Conclusion: 

Successfully adding phosphatidylserine to supplement formulations requires manufacturers to manage the entire supply chain, from raw material selection and dosage form design to stability control and regulatory compliance. Soybean and sunflower-derived products each have their own technological focuses. Soybean-derived products require enhanced antioxidant systems, while sunflower-derived products have advantages in flowability and oxidative stability. Guanjie Biotechnology Co., Ltd. offers bulk phosphatidylserine products with specification customization support and R&D technical support, helping supplement manufacturers shorten formulation development cycles. It is recommended that manufacturers conduct small-scale (1-5 kg) and pilot-scale (50-100 kg) batches before formal production, completing a 6-month accelerated stability study to ensure product quality consistency throughout the entire shelf life.

References

[1] European Commission. Commission Implementing Regulation (EU) 2017/2470 establishing the Union list of novel foods. Official Journal of the European Union. Available at: EUR-Lex.

[2] U.S. Food and Drug Administration (FDA). GRAS Notice Inventory – Phosphatidylserine.

U.S. Department of Health and Human Services. Available at: FDA Official Website.

[3] Food Reviews International. Phosphatidylserine: An overview on functionality, processing techniques, patents, and prospects.